99 related articles for article (PubMed ID: 7660935)
1. Renal clearances of purine bases and oxypurinol during glucose infusion.
Moriwaki Y; Yamamoto T; Takahashi S; Nasako Y; Hada T; Higashino K
Adv Exp Med Biol; 1994; 370():39-42. PubMed ID: 7660935
[No Abstract] [Full Text] [Related]
2. Effect of glucose infusion on the renal transport of purine bases and oxypurinol.
Moriwaki Y; Yamamoto T; Takahashi S; Suda M; Higashino K
Nephron; 1995; 69(4):424-7. PubMed ID: 7777107
[TBL] [Abstract][Full Text] [Related]
3. Effect of lactate infusion on renal transport of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
Nephron; 1993; 65(1):73-6. PubMed ID: 8413795
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
[TBL] [Abstract][Full Text] [Related]
5. Effect of glucagon on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hiroishi K; Yamakita J; Nakano T; Higashino K
J Rheumatol; 1997 Apr; 24(4):708-13. PubMed ID: 9101506
[TBL] [Abstract][Full Text] [Related]
6. Xanthine-containing calculi during allopurinol therapy.
Kranen S; Keough D; Gordon RB; Emmerson BT
J Urol; 1985 Apr; 133(4):658-9. PubMed ID: 3981718
[TBL] [Abstract][Full Text] [Related]
7. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Nasako Y; Higashino K
Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
[TBL] [Abstract][Full Text] [Related]
8. Effect of losartan potassium, an angiotensin II receptor antagonist, on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
J Rheumatol; 2000 Sep; 27(9):2232-6. PubMed ID: 10990239
[TBL] [Abstract][Full Text] [Related]
9. Absorption and metabolism of allopurinol and oxypurinol by rat jejunum in vitro: effects on uric acid transport.
Shaw MI; Parsons DS
Clin Sci (Lond); 1984 Mar; 66(3):257-67. PubMed ID: 6692658
[TBL] [Abstract][Full Text] [Related]
10. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
11. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
13. Deamination of guanine to xanthine: a metabolic pathway of underestimated importance in human purine catabolism?
van Waeg G; Niklasson F; de Verdier CH
Adv Exp Med Biol; 1986; 195 Pt A():425-30. PubMed ID: 3728173
[No Abstract] [Full Text] [Related]
14. Effect of amino acids on the excretions of purine bases and oxypurinol.
Yamamoto T; Moriwaki Y; Takahashi S; Yamakita J; Higashino K
Nephron; 1996; 73(1):41-7. PubMed ID: 8742955
[TBL] [Abstract][Full Text] [Related]
15. Effect of allopurinol on caffeine disposition in man.
Grant DM; Tang BK; Campbell ME; Kalow W
Br J Clin Pharmacol; 1986 Apr; 21(4):454-8. PubMed ID: 3754760
[TBL] [Abstract][Full Text] [Related]
16. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
Reyes AJ; Leary WP
Cardiovasc Drugs Ther; 2005 Oct; 19(5):311-3. PubMed ID: 16382292
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of allopurinol and its metabolite oxypurinol after oral administration of allopurinol alone or associated with benzbromarone in man. Simultaneous assay of hypoxanthine and xanthine by gas chromatography-mass spectrometry.
Lartigue-Mattei C; Chabard JL; Ristori JM; Bussiere JL; Bargnoux H; Petit J; Berger JA
Fundam Clin Pharmacol; 1991; 5(7):621-33. PubMed ID: 1778540
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
[TBL] [Abstract][Full Text] [Related]
19. Cerebral uric acid, xanthine, and hypoxanthine after ischemia: the effect of allopurinol.
Nihei H; Kanemitsu H; Tamura A; Oka H; Sano K
Neurosurgery; 1989 Oct; 25(4):613-7. PubMed ID: 2797398
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
